Literature DB >> 16716644

Isolation of plasmid pKM101 in the Stocker laboratory.

Kristien Mortelmans1.   

Abstract

pKM101 is a mutagenesis-enhancing resistance transfer plasmid (R plasmid) that was introduced into several tester strains used in the Salmonella/microsome mutation assay (Ames test). Plasmid pKM101 has contributed substantially to the effectiveness of the Ames assay, which is used on a world-wide basis to detect mutagens and is required by many government regulatory agencies for approval to market new drugs and other chemical agents. Widely used since 1975, the Ames test is still regarded as one of the most sensitive genetic toxicity assays and a useful short-term test for predicting carcinogenicity in animals. Plasmid pKM101, which is a deletion derivative of plasmid R46 (also referred to as R-Brighton after its origin of isolation in Brighton, England), has also been used to elucidate molecular mechanisms of mutagenesis. It was isolated in the laboratory of Professor Bruce A.D. Stocker at Stanford University as part of my doctoral research with 20 R plasmids. Professor Stocker's phenomenal insight into the genetics of Salmonella typhimurium and plasmid behavior was a major factor that led to the isolation of pKM101. This paper includes a tribute to Bruce Stocker, together with a summary of my research with mutagenesis-enhancing R plasmids and a brief discussion of the molecular mechanisms involved in pKM101 plasmid-mediated bacterial mutagenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16716644     DOI: 10.1016/j.mrrev.2006.03.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Sequencing and comparative genomic analysis of pK29, a 269-kilobase conjugative plasmid encoding CMY-8 and CTX-M-3 beta-lactamases in Klebsiella pneumoniae.

Authors:  Ying-Tsong Chen; Tsai-Ling Lauderdale; Tsai-Lien Liao; Yih-Ru Shiau; Hung-Yu Shu; Keh-Ming Wu; Jing-Jou Yan; Ih-Jen Su; Shih-Feng Tsai
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

2.  An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames predictive potential.

Authors:  Patrick McCarren; Clayton Springer; Lewis Whitehead
Journal:  J Cheminform       Date:  2011-11-22       Impact factor: 5.514

3.  The strains recommended for use in the bacterial reverse mutation test (OECD guideline 471) can be certified as non-genetically modified organisms.

Authors:  Kei-Ichi Sugiyama; Masami Yamada; Takumi Awogi; Atsushi Hakura
Journal:  Genes Environ       Date:  2016-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.